Other formats:
BibTeX
LaTeX
RIS
@article{492256,
author = {Zatloukal, Petr and Petruzelka, Luboš and Zemanová, Milada and Kolek, Vítězslav and Skřičková, Jana and Pešek, Miloš and Sixtová, Dimka and Roubec, Martin and Havel, Libor and Pruša, Petr},
article_number = {sup 2},
keywords = {Non Small Cell Lung Cancer; Stage IIIb and IV; Gemcitabine; Cisplatin; Carboplatin},
language = {eng},
issn = {0169-5002},
journal = {Lung Cancer},
note = {10th World Conference on Lung Cancer, 10-14 August, Vancouver, Canada},
title = {Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin in Stage IIIb and IV Non Small Lung Cancer: A phase III Randomized Trial},
volume = {41},
year = {2003}
}
TY - JOUR
ID - 492256
AU - Zatloukal, Petr - Petruzelka, Luboš - Zemanová, Milada - Kolek, Vítězslav - Skřičková, Jana - Pešek, Miloš - Sixtová, Dimka - Roubec, Martin - Havel, Libor - Pruša, Petr
PY - 2003
TI - Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin in Stage IIIb and IV Non Small Lung Cancer: A phase III Randomized Trial
JF - Lung Cancer
VL - 41
IS - sup 2
SP - 65
EP - 65
SN - 01695002
N1 - 10th World Conference on Lung Cancer, 10-14 August, Vancouver, Canada
KW - Non Small Cell Lung Cancer
KW - Stage IIIb and IV
KW - Gemcitabine
KW - Cisplatin
KW - Carboplatin
N2 - The ranomized, muticenter, phase III trial was conducted to compare the tolerability of gemcitabine plus cisplatine (GP) vs. gemcitabine plus carpolatin (GC). The enroled patients in GC and GP arm were balanced for demographic and disease characteristics. Both GP and GC are ffective options, the GC arm offering the advantage to pts unable to receive cisplatin.
ER -
ZATLOUKAL, Petr, Luboš PETRUZELKA, Milada ZEMANOVÁ, Vítězslav KOLEK, Jana SKŘIČKOVÁ, Miloš PEŠEK, Dimka SIXTOVÁ, Martin ROUBEC, Libor HAVEL and Petr PRUŠA. Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin in Stage IIIb and IV Non Small Lung Cancer: A phase III Randomized Trial. \textit{Lung Cancer}. 2003, vol.~41, sup 2, p.~65. ISSN~0169-5002.
|
